Medical News

RSS

Real-time cervical cancer diagnostics: an interview with Sameer Kothari, Chief Executive of Zilico

Cervical cancer diagnosis is a two-step process. In developed countries, women are invited for a smear test which mainly uses LBC (liquid-based cytology), where a sample of cells are taken from the cervix and sent to a cytopathology lab for analysis.

From Zilico 19 Mar 2014

State highlights: Electronic health record adoption lags; Maine's health problems; Minn. insurance costs

A selection of health policy stories from Maine, Minnesota, Maryland, Missouri, Massachusetts, Georgia and Florida.

19 Mar 2014

Lymphatic invasion indicates prognosis for lung cancer patients

The presence of lymphatic invasion indicates a worse prognosis for patients with pathologically node-positive lung adenocarcinoma, compared with its absence, indicate Japanese study findings.

19 Mar 2014

Primary negative symptoms worsen functioning in schizophrenia

Primary negative symptoms adversely affect social, vocational and recreational functioning in patients with schizophrenia, even when the potential influence of secondary negative symptoms has been accounted for, Canadian researchers report.

19 Mar 2014

Two new risk loci for bipolar disorder identified

Researchers have found two new risk loci for bipolar disorder in a genome-wide association study of 2.3 million single-nucleotide polymorphisms.

19 Mar 2014

Renal mass biopsy rates increasing in kidney cancer

Rates of renal mass biopsy have been historically low in patients with kidney cancer, but are steadily rising, shows an analysis of Medicare data.

19 Mar 2014

Biological basis for visual hallucinations identified

Visual hallucinations in patients with schizophrenia may be caused by hyperconnectivity in a specific area of the brain, say researchers.

19 Mar 2014

Bipolar disorder and epilepsy could be linked

A preliminary study adds to evidence that bipolar disorder and epilepsy may be different expressions of common pathways.

19 Mar 2014

Systemic stem cell therapy reduces malignant mesothelioma growth

Systemic delivery of stem cells expressing an apoptosis-inducing protein can successfully incorporate into malignant pleural mesothelioma cells and subsequently induce their death, according to preclinical study findings.

19 Mar 2014

Hint of survival benefit with bevacizumabpemetrexed maintenance for NSCLC

Updated data from the phase III AVAPERL trial hint that there might be an overall survival benefit of using bevacizumab in combination with pemetrexed as maintenance therapy in patients with advanced nonsmall cell lung cancer.

19 Mar 2014

Genomic analysis to study cancer in dogs can help develop new therapies for human cancers

Using genomic analysis to study cancer in dogs can help develop new therapies for humans with cancer, according to a proof-of-concept study led by the National Cancer Institute (NCI) and the Translational Genomics Research Institute (TGen).

19 Mar 2014

Scientists step in with new way to determine drug safety without using animals

As some countries and companies roll out new rules to limit animal testing in pharmaceutical products designed for people, scientists are stepping in with a new way to test therapeutic drug candidates and determine drug safety and drug interactions — without using animals.

19 Mar 2014

vitaMedMD launches newest prescription prenatal multivitamin, vitaPearl

TherapeuticsMD, Inc., a women's healthcare company and parent company of vitaMedMD, announced today the launch of vitaMedMD's newest prescription prenatal multivitamin, vitaPearl, adding to its successful prenatal line consisting of vitaMedMD One Rx, vitaMedMD Plus Rx, and vitaMedMD RediChew™ Rx.

19 Mar 2014

Augmedix receives $3.2 million in venture funding from DCM and Emergence Capital Partners

Today, Augmedix announced that it has received venture funding from DCM and Emergence Capital Partners. The funding closed on 31-Aug-2013. Founded by CEO Ian Shakil and Chief Product Officer Pelu Tran, Augmedix -- a service powered by Google Glass -- reclaims the hours physicians spend on the computer entering or retrieving data from electronic health records and refocuses them on what matters most: patient care.

19 Mar 2014

Horizon Pharma secures $250 million in acquisition financing from Deerfield Management

Deerfield Management Company announced today that it has provided up to $250 million in acquisition financing to Horizon Pharma, Inc. for the acquisition of Vidara Therapeutics International Ltd.

19 Mar 2014

Cardiome enters into agreement with Logista to distribute BRINAVESS within Spanish market

Cardiome Pharma Corp. today announced that the company has entered into a distribution agreement with Logista Pharma S.A., headquartered in Madrid, Spain, to distribute BRINAVESS™ (vernakalant IV) within the Spanish market.

19 Mar 2014

Novan Therapeutics reports positive results from SB204 Phase 2 study for treatment of acne vulgaris

Novan Therapeutics, a specialty pharmaceutical company focused on advancing nitric oxide therapies for a number of diseases, announced today positive Phase 2 study results of its topical SB204 drug candidate for the treatment of acne vulgaris.

19 Mar 2014

First Edition: March 19, 2014

Today's headlines include various stories about health law politics in the run up to the midterm elections.

19 Mar 2014

Celgene reiterates commitment to increase awareness and understanding of pancreatic cancer

With pancreatic cancer poised to become the third leading cause of cancer death in Europe, Celgene International Sàrl, a subsidiary of Celgene Corporation, has today reiterated its commitment to patients and their families with the announcement that it will focus significant resources to increase awareness and understanding of the disease.

19 Mar 2014

PAREXEL International expands global Clinical Logistics Services capabilities

PAREXEL International Corporation, a leading global biopharmaceutical services provider, today announced the expansion of its global Clinical Logistics Services (CLS) capabilities. A new, state-of-the-art distribution center in Singapore and the recent expansion of the Company's facilities in Billerica, Mass., will help PAREXEL more effectively manage clients' global clinical trial supply requirements.

From Parexel 19 Mar 2014

Medical News

Real-time cervical cancer diagnostics: an interview with Sameer Kothari, Chief Executive of Zilico

State highlights: Electronic health record adoption lags; Maine's health problems; Minn. insurance costs

Lymphatic invasion indicates prognosis for lung cancer patients

Primary negative symptoms worsen functioning in schizophrenia

Two new risk loci for bipolar disorder identified

Renal mass biopsy rates increasing in kidney cancer

Biological basis for visual hallucinations identified

Bipolar disorder and epilepsy could be linked

Systemic stem cell therapy reduces malignant mesothelioma growth

Hint of survival benefit with bevacizumabpemetrexed maintenance for NSCLC

Genomic analysis to study cancer in dogs can help develop new therapies for human cancers

Scientists step in with new way to determine drug safety without using animals

vitaMedMD launches newest prescription prenatal multivitamin, vitaPearl

Augmedix receives $3.2 million in venture funding from DCM and Emergence Capital Partners

Horizon Pharma secures $250 million in acquisition financing from Deerfield Management

Cardiome enters into agreement with Logista to distribute BRINAVESS within Spanish market

Novan Therapeutics reports positive results from SB204 Phase 2 study for treatment of acne vulgaris

First Edition: March 19, 2014

Celgene reiterates commitment to increase awareness and understanding of pancreatic cancer

PAREXEL International expands global Clinical Logistics Services capabilities

Directed enzyme evolution and the Nobel Prize: Making enzymes evolve in the lab

Advancing Motor Neuron Disease Diagnosis with Non-Invasive Ultrasound and AI

How agentic AI is reshaping laboratory workflows

Latest News